South Africa will delay introducing a new HIV and TB plan until 2024, Deputy President David Mabuza revealed on Wednesday. The plan is delayed to allow the country’s HIV and TB responses to recover from COVID-19-related disruptions. Laura Lopez Gonzalez reports for Spotlight.
One of the biggest challenges now facing South Africa’s HIV response is how to support many more people living with HIV to engage or re-engage and then stay on treatment. One way to make it easier for people living with HIV to adhere to treatment is to provide a longer supply of medicines, argues Ndivhuwo Rambau & Simphiwe Xaba.
From March to July this year, the Gauteng Department of Health recorded 57 848 TB tests – a decrease of about 30 000 tests compared to the same period last year. The province performed better with HIV testing, although the HIV response has faltered in other areas. Melissa Javan makes sense of the province’s numbers and speaks to activists and community health workers about the impact of lockdown on their services and plans to get things back on track.
Two decades since Doctors without Borders (MSF) started its HIV programme in Khayelitsha, the organisation will start wrapping up its operations. Siyabonga Kamnqa spoke to some people living with HIV who benefitted from this programme and who now work as activists about developments over the last 20 years.
While South Africa is doing well on some of the UNAIDS HIV targets for 2020, one target we are set to miss is ensuring that 90% of people diagnosed with HIV are on antiretroviral therapy. Partly in response to this problem, the ‘Welcome back’ campaign started by Doctors without Borders aims to make it easier for people who have stopped taking treatment to restart. Tiyese Jeranji reports.
While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers on Tuesday have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.
Stigma and discrimination makes accessing healthcare services hard for many young people living with HIV. Has it become even harder during the COVID-19 pandemic? Nomfundo Xolo spoke to young people and activists in KwaZulu-Natal.
Concerns are mounting over people stopping or not starting tuberculosis and HIV treatment during South Africa’s COVID-19 lockdown. Nomfundo Xolo spoke to activists and people living with HIV and TB in Hammonds Farm in Verulam in KwaZulu-Natal about the challenges they face.
Reports of drug shortages and stock-outs across South Africa have the Department of Health in a race against the clock to ensure a supply of essential medicines. With manufacturing operations around the world still facing issues due to the COVID-19 pandemic, the country is battling to meet the demand for contraceptives, tuberculosis medicines and psychiatric medicines.